Member Announcements 2010

 

December 21, 2010

BIOLUX RESEARCH ANNOUNCES START OF NEW CLINICAL TRIAL FOR LIGHT-ACCELERATED ORTHODONTICS
 

 

December 13, 2010

Inimex Pharmaceuticals and SARomics Biostructures announce successful achievement of key scientific milestone in structural biology collaboration
 

 

December 10, 2010

UBC launches initiative with CCFF, CDRD to combat cystic fibrosis
 

 

December 9, 2010

UVIC Biomedical Engineer “Outsmarts” HIV
 

 

December 8, 2010

iCo Therapeutics Grants License Option for Bertilimumab (iCo-008) Systemic Uses to Immune Pharmaceuticals for US$33 Million Plus Royalties
 

 

December 7, 2010

EnWave Acquires U.S. Patents and Know-how for MIVAPTM Technology and Enters Long Term Global Marketing and Strategic Supply Agreement with Hans Binder Maschinenbau GmbH
 

 

December 7, 2010

UBC-developed formulation of leishmaniasis drug shown to be stable and effective in tropical temperatures
 

 

December 6, 2010

enGene, Inc. CSO to Present Key Pre-Clinical Data on EG-10 for Treating Inflammatory Bowel Disease
 

 

December 3, 2010

UBC/CFRI project receives $7M to reduce maternal, fetal, and newborn deaths
 

 

December 2, 2010

Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreement and Cure Period under Subordinated Note Indenture
 

 

December 2, 2010

Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. Litigation
 

 

November 30, 2010

Allon receives Michael J. Fox Foundation grant for Parkinson’s disease research
 

 

November 30, 2010

Progressive Health Innovations Completes Distribution Deal With Collins Sports Medicine
 

 

November 30, 2010

14 Farris Lawyers Recognized in the 2011 Best Lawyers in Canada Directory
 

 

November 29, 2010

BC researchers use “virtual screening” to fight the deadliest forms of prostate cancer
 

 

November 29, 2010

ANGIOTECH PHARMACEUTICALS ANNOUNCES Private Label Product Supply Agreement With Hologic
 

 

November 29, 2010

Cardiome to Present at Piper Jaffray Healthcare Conference
 

 

November 29, 2010

SIRONA BIOCHEM Receives Funding From Going Global Innovation
 

 

November 26, 2010

iCo Therapeutics Reports Third Quarter 2010 Financial Results

 

 

November 26, 2010

James Hatton Appointed Queen’s Counsel
 

 

November 25, 2010

UNBC Fires Up Bioenergy System
 

 

November 25, 2010

eHealth Researcher Awarded National Distinction
 

 

November 24, 2010

UBC Innovation is Advanced by the Centre for Drug Research and Development and Licensed by Global Healthcare Company
 

 

November 24, 2010

Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LP
 

 

November 24, 2010

Tracking potential HIV moms in Africa
 

 

November 23, 2010

Aubrey J. Tingle Prize: A Legacy for BC
 

 

 

November 22, 2010

Premier Dianostics & PET-CT
 

 

November 22, 2010

BCIC Appoints New CEO
 

 

November 22, 2010

Dalhousie University Signs Affiliation Agreement with the Centre for Drug Research and Development
 

 

November 22, 2010

Tekmira Intellectual Property Portfolio Expands With Granting of Key Patents Covering LNP Manufacturing and Mitigation of siRNA Immune Stimulation
 

November 19, 2010

Genome BC, Chile and Norway enter next phase in sequencing the critical Atlantic salmon genome
 

 

November 19, 2010

PROTOX Closes First $10 Million Tranche Of Warburg Pincus Investment
 

 

November 19, 2010

HIV prevention research to grow in Africa
 

 

November 19, 2010

Genome BC, Chile, Norway Enter next phase in sequencing the critical Atlantic salmon genome
 

 

November 17, 2010

Backgrounder: Scientists capture antimatter atoms
 

 

November 17, 2010

UBC’s Hertzman rewarded for early childhood research
 

 

November 17, 2010

Ripples Of Hope Pfizer Award Granted To Two Dedicated Researchers
 

 

November 17, 2010

Tekmira Pharmaceuticals Comments on Roche Restructuring
 

 

November 17, 2010

UBC researchers create iridescent glass that can reflect UV or infrared light
 

November 17, 2010

Mr. Paul Lucas Appointed New Chair, Rx&D Board of Directors
 

November 16, 2010

BC Cancer Agency licensing lung cancer detection device
 

 

November 16, 2010

Isis and Xenon Collaborate to Develop Antisense Drugs Against Hemojuvelin and Hepcidin
 

 

November 16, 2010

Call for Applications: The Amgen Award for Science Teaching Excellence
 

 

November 16, 2010

Protox Obtains Sharehoder Approval For Investment By Warburg Pincus Of Up To $35 Million
 

 

November 15, 2010

Tekmira Pharmaceuticals Announces Third Quarter 2010 Financial Results
 

 

November 11, 2010

Cardiome Reports Third Quarter Results
 

 

November 10, 2010

Allon’s Founding Scientist Illana Gozes awarded Olson Prize from PEPTIDES journal
 

 

November 9, 2010

ANGIOTECH PHARMACEUTICALS, INC. Announces Financial Results For The Third Quarter Ended September 30, 2010
 

 

November 9, 2010

NEOVASC INC. Reports Financial Results For The Third Quarter Of 2010
 

 

November 9, 2010

Sirona Biochem To Attend Bio-Europe 2010 Conference In Munich, Germany
 

 

November 8, 2010

OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
 

 

November 8, 2010

New Western Canada Innovation Agreement Creates Jointly Managed Fund to Advance Health Sciences Discoveries and Enable Commercialization of New Therapeutics
 

 

November 4, 2010

Allon Receives Qualifying Therapeutic Discovery Project Grants for Drug Development From U.S. Government
 

 

November 4, 2010

Ondine Awarded QTDP Grant for Non-Antibiotic MRSA Decolonization Technology
 

 

November 4, 2010

OncoGenex Reports Third Quarter Financial Results
 

 

November 4, 2010

Sirona Biochem Receives Funding From the National Research Council Industrial Research Assistance Program
 

 

November 4, 2010

Innovation leads the way with the 2010 Strategic Opportunities Fund recipients
 

 

November 3, 2010

Tekmira Provides Update On NASDAQ Listing
 

 

November 3, 2010

QLT Announces Third Quarter Results For 2010
 

 

November 2, 2010

In conversation with Eric Adams
 

 

November 1, 2010

Cardiome to Present at Oppenheimer Healthcare Conference
 

 

November 1, 2010

Allon Completes U.S. $10 Million Financing Agreement with Nordic Biotech Entity
 

 

November 1, 2010

Cardiome to Present at Oppenheimer Healthcare Conference
 

 

October 29, 2010

Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated Noteholders and Floating Rate Noteholders
 

 

October 29, 2010

Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
 

 

October 28, 2010

Is our too clean culture making our kids sick?
 

 

October 28, 2010

Sirona Biochem Closes Over-Subscribed Non-Brokered Private Placement
 

 

October 28, 2010

QLT Announces expaneion of phase 1b study of oral synthetic retinoid compound
 

 

October 28, 2010

SFU tops in research publication impact
 

 

October 27, 2010

SFU seeds discovery of mutant gene in chromosomes
 

October 25, 2010

Province unites to fight breast cancer before it starts: New Provincial Breast Health Strategy unveiled
 

 

October 22, 2010

OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering
 

 

October 21, 2010

OncoGenex to Webcast Third Quarter Financial Results on Thursday, November 4, 2010
 

 

October 21, 2010

Tekmira and Collaborators at the NCI Publish Promising Preclinical Data Demonstrating Anti-Tumor Activity of a Novel Cancer Target via RNA Interference
 

 

October 21, 2010

Cardiome Announces Suspension of Enrollment in ACT 5 Trial
 

 

October 20, 2010

UNBC and Harvard: #1 Campus Sustainability Projects in North America
 

 

October 20, 2010

UVic Shines in 2010 National Research Rankings
 

 

October 19, 2010

BC Cancer Agency scientists uncover strategy to effectively target drug resistant childhood cancers
 

 

October 18, 2010

Genome BC Chief Scientific Officer to Head Genome Canada
 

 

October 14, 2010

Research on the balance of bacteria in women’s bodies holds key to improving women’s health
 

 

October 14, 2010

Genome British Columbia: Reserach on the Balance of Bacteria in Women’s Bodies Holds Key to Improving Women’s Health
 

 

October 13, 2010

iCo Therapeutics Selected as Canada’s Top 10â„¢ Competition Winner

 

 

October 13, 2010

Angiotech Pharmaceuticals Announces Conference Call and Webcast
 

 

October 12, 2010

Sirius Genomics and Golden Helix Collaborate on Companion Diagnostic Development
 

 

October 11, 2010

Ondine Announces Share Consolidation and Name Change
 

 

October 8, 2010

Pilot clinical trial meets primary endpoint with Allon’s davunetide
 

 

October 8, 2010

WEX Announces Retirement of Vice President, Research and Development
 

 

October 7, 2010

Tekmira Intellectual Property Portfolio Solidified with Granting of Key Patents by US Patent & Trademark Office
 

 

October 7, 2010

UNBC to Celebrate International Award for Bioenergy Program
 

 

October 6, 2010

Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against the Company And Certain of Its Subsidiaries
 

 

October 5, 2010

Sirius Genomics Receives NRC-IRAP Funding for Development of New Biomarkers
 

October 5, 2010

T cell discovery shows promise for Type 1 diabetes treatment: UBC-CFRI study
 

 

October 1, 2010

Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes
 

 

September 30, 2010

Teva and OncoGenex Announce Initiation of Second Phase 3 Trial of Custirsen in Men with Metastatic Prostate Cancer
 

 

September 30, 2010

OWGM Does it Again!
 

 

September 29, 2010

iCo Therapeutics Oral Amphotericin Program Receives FDA Orphan Drug Status

 

 

September 29, 2010

Ondine Announces Proposed Share Consolidation and Name Change
 

 

September 29, 2010

Warburg Pincus Agrees to Invest Up to $35 Million in Protox
 

 

September 28, 2010

James Hatton Recognized as One of The World’s 250 Leading Patent and Technology Licensing Lawyers
 

 

September 28, 2010

UVIC Student Recognized for Vaccine Technology
 

 

September 27, 2010

Neovasc Reducer(TM) for Refractory Angina Featured in Live Case Session at TCT 2010 Conference
 

 

September 27, 2010

OncoGenex Pharmaceuticals Announces Initiation of a Phase 2 Trial Evaluating OGX-427 Treatment in Men with Advanced Prostate Cancer
 

 

September 27, 2010

WEX Announces Update on Interim Analysis
 

 

September 27, 2010

PET CT program gets major boost with new facility
 

 

September 25, 2010

ANGIOTECH ANNOUNCES THREE YEAR DATA FROM THE HORIZONS-AMI TRIAL PROVIDES SUPERIOR OUTCOMES WITH BOSTON SCIENTIFIC CORPORATION’S TAXUS(R) DRUG-ELUTING STENT IN HEART ATTACK PATIENTS
 

 

September 24, 2010

ANGIOTECH ANNOUNCES THAT COOK MEDICAL’S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-CENTER, PIVOTAL CLINICAL TRIAL
 

 

September 24, 2010

2010 BCIC Awards and BCIC-New Ventures Competition award $391,000 to Tech entrepreneurs
 

 

September 23, 2010

Carl Wieman to take up White House post
 

 

September 22, 2010

iCo Therapeutics Appoints Infectious Disease Experts to Scientific Advisory Board
 

 

September 22, 2010

ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONS
 

 

September 22, 2010

ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION’S PLATINUM CHROMIUM TAXUS(R) ELEMENT(TM) STENT SYSTEM
 

 

September 21, 2010

Genomic ‘Haircut’ Makes World’s Tiniest Genome Even Smaller
 

 

September 20, 2010

OncoGenex Pharmaceuticals, Inc. – Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
 

 

September 20, 2010

Neovasc Initiates Patient Enrollment in COSIRA Trial of Reducerâ„¢ Product for Refractory Angina
 

 

September 14, 2010

Progressive Health Innovations Announces Issuance of US Patent
 

 

September 13, 2010

The Centre for Drug Research and Development Appoints John Babcook as Vice President of new Biologics Division
 

 

September 13, 2010

First-of-its-kind study shows supervised injection facilities can help people quit drugs
 

 

September 8, 2010

Tekmira Pharmaceuticals Strengthens Management Team With Addition of Paul Brennan as Senior Vice President, Business Development
 

 

September 7, 2010

Tekmira Pharmaceuticals Receives Clearance From FDA to Initiate TKM-PLK1 Phase 1 Clinical Trial
 

 

September 7, 2010

OncoGenex Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference and the UBS Global Life Sciences Conference
 

 

September 7, 2010

Cancer diagnosis and treatment move another step forward
 

 

September 7, 2010

Media Advisory: Gene Screen BC Screening Gala, Sept. 8th
 

 

September 7, 2010

Royal Society of Canada recognizes SFU biologist
 

 

September 2, 2010

enGene Adds Leading Nanomedicine Expert To Scientific Advisory Board
 

 

September 2, 2010

Celator ® Pharmaceuticals Raises $20 Million In Series D Financing
 

 

September 2, 2010

Cardiome Achieves $30 Million Milestone
 

 

September 1, 2010

BRINAVESS(tm) (vernakalant) for Infusion Approved in the European Union for Rapid Conversion of Recent Onset Atrial Fibrillation
 

 

August 24, 2010

Minister Lynne Yelich Announces Funding for Technology Upgrades for Improved Nuclear Medicine at TRIUMF
 

 

August 24, 2010

Sirona Biochem Signs Binding Preliminary Agreement to Acquire TFChem
 

 

August 23, 2010

Federal, Provincial Funding Supports BC Life Science
 

 

August 17, 2010

Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology Patented Technology Used in Aortic and Peripheral Vascular Applications
 

 

August 17, 2010

Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402
 

 

August 12, 2010

Tekmira Pharmaceuticals Announces Second Quarter 2010 Financial Results
 

 

August 11, 2010

Alectos Therapeutics Announces Collaboration With Merck to Develop Drugs for Alzheimer’s Disease
 

 

August 11, 2010

Allon Therapeutics Releases Second Quarter Operating Results
 

 

August 11, 2010

Cardiome Reports Second Quarter Results and Updates Guidance
 

 

August 11, 2010

Breakthrough heralds era of personalized cancer treatment
 

 

August 10, 2010

Personalized genome sequencing in cancer treatment—a major breakthrough in care
 

 

August 10, 2010

Tekmira Pharmaceuticals Conference Calll Advisory Second Quarter 2010 Operating Results and Corporate Update
 

 

August 10, 2010

OncoGenex Adds David V. Smith to the Board of Directors
 

 

August 10, 2010

Response Biomedical Corporation Announces Second Quarter Results
 

 

August 9, 2010

Heart Force Medical Appoints Dave Bonar
 

 

August 9, 2010

Invention’s bit of gold goes a long way
 

 

August 6, 2010

OncoGenex Reports Second Quarter Financial Results
 

 

August 5, 2010

Tekmira Pharmaceuticals Files IND Application With U.S. FDA for PLK1 SNALP
 

 

August 3, 2010

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010
 

 

July 26, 2010

iCo Therapeutics Inc. Receives Health Canada Clearance to Conduct Phase II DME Trial With iCo-007
 

 

July 19, 2010

Biolux Research Announces Financing For Continued Development of its Light Accelerated Orthodontics Product
 

 

July 19, 2010

Allon Receives New Economy 2010 Pharmaceutical & Healthcare Award for Drug Development Innovation
 

 

July 16, 2010

UBC Pharmaceutical Sciences Building groundbreaking ceremony
 

 

July 15, 2010

Tekmira Awarded up to $140 Million U.S. Government Contract to Develop RNAi Therapeutic Against Ebola Virus
 

 

July 9, 2010

UBC welcomes $3.3 million from two federal research programs
 

July 9, 2010

Urodynamix Technologies Ltd. (URO.V) Enters into Definitive Agreement for Sale of NIRS Business to HEGLN For CAD 2.1 Million ($2.03 Million)
 

 

July 8, 2010

Angiotech Pharmaceuticals announces notice of failure to satisfy a continued listing rule with The Nasdaq Stock Market.
 

 

July 7, 2010

Dr. Tomlinson Joins Wax-it Histology Services as Lead Pathologist
 

 

July 7, 2010

Ondine Receives Letters of Intent for Sale of Majority Interest in Sinusitis Subsidiary
 

 

July 6, 2010

Tekmira’s Partner Alnylam Initiates Dosing in a Phase 1 Clinical Trial of ALN-TTR01
 

 

June 30, 2010

Ondine Announces Debt Financing
 

 

June 30, 2010

Sirius Genomics Announces Appointment of Senior Director of Business Development
 

 

June 29, 2010

Ondine To Form Chronic Sinusitis Treatment Subsidiary
 

 

June 29, 2010

Allon to address pharma executives at Euro-Biotech Forum
 

 

June 29, 2010

Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors
 

 

June 28, 2010

Response Biomedical Corporation Announces Subscription Agreement for $8 Million Private Placement
 

 

June 28, 2010

QLT added to the Russell index
 

 

June 25, 2010

Investigational BRINAVESSâ„¢ (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation
 

 

June 24, 2010

British Consulate General in Vancouver Appoints new Science, Innovation & Energy Officer
 

 

June 24, 2010

Biolux Research announces filing of patent application for regulation of orthodontic tooth movement
 

 

June 23, 2010

Terasen looks to expand into clean-energy market Gas utility plans to launch bio-methane recovery program and may pursue the development of geothermal and solar energy systems
 

 

June 22, 2010

QLT announces final results from its radical study evaluating verteporfin PDT combination therapy in exudative AMD
 

 

June 22, 2010

UNBC and Northern Health Sign Memorandum of Understanding
 

 

June 21, 2010

OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
 

 

June 21, 2010

Forum starts mapping out a sustainable energy future
 

 

June 21, 2010

Seeking Biomarker Solutions for South Asians PROOF Centre of Excellence Partners with the Canada India Network Society
 

 

June 21, 2010

Aubrey J. Tingle Prize Presented to Dr. Julio Montaner
 

 

June 15, 2010

Novozymes and Lignol sign deal to make biofuel from wood
 

 

June 14, 2010

Genome BC, Chile and Norway take another step closer to fully sequencing the salmon genome
 

 

June 11, 2010

UBC-VCH researchers funded by MS Society to investigate the validity of CCSVI
 

 

June 11, 2010

BC scientists develop new drug candidate for prostate cancer
 

 

June 11, 2010

Angiotech’s Licensee,Cook Medical,files PMA submission for FDA approval of ZILVE PTX ® Drug-Eluting stent platform
 

 

June 10, 2010

Biolux Research announces presentation of accelerated orthodontic study results at international association for dental research general session 2010
 

 

June 9, 2010

Kinexus Cracks the Protein Kinase Specificity Code – Prediction of over 4.6 million human-kinase-substrate interactions available in PhosphoNET website
 

 

June 8, 2010

Pacgen Completes Share Consolidation
 

 

June 8, 2010

EnWave Provides Progress Report on IFS/SmartPac Letter of Intent
 

 

June 8, 2010

Allon’s CEO Presenting at Needham Annual Healthcare Conference
 

 

June 7, 2010

OncoGenex Pharmaceuticals Announces Final Results from Phase 1 Trial Evaluating OGX-427 as a Treatment for Solid Tumors
 

 

June 7, 2010

Tekmira Partner Alnylam Presents ALN-VSP Preliminary Phase 1 Clinical Trial Results at American Society of Clinical Oncology (ASCO) Annual Meeting
 

 

June 7, 2010

Personalized Medicine Gets a Welcomed Boost from Genome BC
 

 

June 4, 2010

Discovery advances control of starch digestion
 

 

June 4, 2010

New funding boosts UVic forest and climate research
 

 

June 4, 2010

UBC Receives $1.2 Million to Develop Microbial Indicators of Forest Health
 

 

June 3, 2010

Micro-organisms in soil could help BC forests in the fight against climate change
 

 

June 2, 2010

Ondine Biopharma CEO Nominated for Manning Innovation Award
 

 

June 2, 2010

EnWave Wins Prestigious Canadian Technology Award
 

 

June 1, 2010

EnWave Completes Warrant Exercise, Generating $3.2M in Cash
 

 

June 1, 2010

The Centre for Drug Research and Development and Vancouver Prostate Centre Sign a Preferred Collaboration Agreement
 

 

May 28, 2010

Tekmira Reports Complete Protection from Deadly Ebola Virus in Nonhuman Primates with SNALP-RNAi -Data Reflects High Potency and Utility of RNAi in Infectious Disease Applications
 

 

May 25, 2010

iCo Therapeutics Inc. Enters Into Technology Transfer Agreement With Isis Pharmaceuticals, Inc. For iCo-007
 

 

May 20, 2010

McMaster University Signs Affiliation Agreement with the Centre for Drug Research and Development
 

 

May 20, 2010

QLT Announces Its Intention to Increase Share Repurchase Program
 

 

May 17, 2010

Response Biomedical Corporation Granted Class 3 Medical Device License by Health Canada to Market RSV Assay in Canada
 

 

May 17, 2010

Neovsc Inc. reports finanacial results for the first quarter of 2010 -Three-Fold increase in revenues marks fifth consecutive quarter of top-line and bottom-line growth –
 

 

May 17, 2010

Inaugural Canada Excellence Research Chair appointed to UBC :up to $10M towards research in Parkinson’s, neurodegenerative disorders in adults and children
 

 

May 13, 2010

Allon Therapeutics releases first quarter operating results
 

 

May 12, 2010

Tekmira Pharmaceuticals Outlines Plans for a NASDAQ Listing
 

 

May 12, 2010

Cupples and Craig named SFU’s newest deans
 

 

May 11, 2010

Allon Therapeutics Announces Publication of davunetide Data Demonstrating Cognition Improvement in Schizophrenia Model
 

 

May 10, 2010

Tekmira Pharmaceuticals Announces Multi-Year Agreement with Bristol-Myers Squibb Transaction includes US$3.0 million upfront payment to Tekmira
 

 

May 10, 2010

Biolux Research announces presentation of the osseopulse at Ontario dental association annual spring meeting 2010.
 

 

May 6, 2010

QLT boosts revenue despite Visudyne sales slide
 

 

May 6, 2010

OncoGenex Reports First Quarter Financial Results
 

 

May 6, 2010

QLT announces first quarter result for 2010
 
 

May 5, 2010

New fund accelerates genomics innovation from the lab to the marketplace
 

 

May 4, 2010

Angiotech Pharmaceuticals Inc. announces financial results for the first quarter ended March 31,2010
 

 

April 30, 2010

The Centre for Drug Research and Development (CDRD) Creates International Partnership with Griffith University’s Eskitis Institute in Queensland, Australia
 
 

April 26, 2010

Biolux Research Announces Design Award for the OsseopulseTM Bone Regeneration System for Implantology
 
 

April 20, 2010

QLT Announces Positive Interim Results From Phase 1b Study of its Oral Synthetic Retinoid Compound in Leber Congenital Amaurosis
 

 

April 16, 2010

BioMers introduces new aesthetic products for orthodontic treatment
 

 

April 6, 2010

Allon Therapeutics, Inc. Announces Davunetide Receives FDA Fast Track Status for Treatment of Progressive Supranuclear Palsy
 

 

April 6, 2010

Allon Treads Into the Great Unknown, Alzheimer’s Disease, With New Kind of Drug
 
 

April 6, 2010

PROOF Centre of Excellence Joins Forces with Luminex Corporation to Improve Health Outcomes of Transplant
 
 

April 6, 2010

WEX to Present at BioFinance 2010 Conference
 
 

March 25, 2010

Ondine Biopharma Announces 2009 Year End Financial Results
 
 

March 24, 2010

FDA Accepts Filing of Ondine’s Pre-Market Approval (PMA) Application for Periowaveâ„¢ Photodisinfection System
 

 

March 17, 2010

Allon Receives European Orphan Drug Status for Davunetide
 

 

March 17, 2010

UPDATE 2-Tekmira shares surge on Pfizer collaboration
 

 

March 16, 2010

Tekmira and Pfizer Initiate New Research Collaboration
 

 

March 16, 2010

Kinexus Announces the Launch of New Peptide Production Services New Peptide Array Facility Designed to Expedite the Drug Discovery Process
 

 

March 8, 2010

Allon Adopts Shareholder Rights Plan
 

 

March 2, 2010

FDA Approves Exalgo(TM) Extended-Release Tablets
 
 
 February 19, 2010
Neovasc Completes Final Tranche of $1.537 Million Non -Brokered Private Placement
 
 

February 17, 2010

BioPartnering North America(TM) (BPN) Sets the Stage for Partnering in 2010
 

February 16, 2010

E-mail visionary sees future in plants
 

 

February 16, 2010

Cardiome Pharma Corp. Announces US$25 Million Advance on Line of Credit
 

 

February 15, 2010

pr02151001.asp
 

 

February 10, 2010

Kinexus Announces the Launch of New Protein Kinase Microarray New kinase array designed for drug screening, substrate profiling and kinase interaction discovery
 
 

January 21, 2010

Genomic Surveillance of Pandemic H1N1
 
 

January 20, 2010

Legal Update: New Protection for Licensees of Intellectual Property – Recent Amendments to Canada’s Bankruptcy and Insolvency Act and Companies’ Creditors Arrangement Act
 
 

January 19, 2010

Tekmira Makes Significant Improvements in the Potency of Its Leading RNAi Delivery Platform
 

 

January 14, 2010

Call For Applications: The Amgen Award for Science Teaching Excellence (AASTE)
 

 

January 12, 2010

Sunflower genome holds the promise of sustainable agriculture
 

 

January 11, 2010

GenomeDx Explores New Diagnostic Tools for Prostate Cancer Using Personalized Genomics